GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study

PHASE4CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Peripheral Vascular Diseases
Interventions
DEVICE

GORE VIABAHN Endoprosthesis

Implantation

DEVICE

Bare Nitinol Stent

Implantation

Trial Locations (15)

15009

Heritage Valley Health Systems, Beaver

15212

Allegheney General Hospital, Pittsburgh

30106

Vascular Surgical Associate, Austell

33308

Holy Cross Hospital, Fort Lauderdale

43214

Midwest Cardiology Research Foundation, Columbus

44195

The Cleveland Clinic Foundation, Cleveland

53215

St Luke's Medical Center, Milwaukee

60148

Midwest Heart Foundation, Lombard

60160

Midwest Institute for Minimally Invasive Therapy, Melrose Park

61637

St Francis Medical Center, Peoria

62701

St. Johns Hospital/Prairie Education Research, Springfield

63110

Washington University, St Louis

70121

Ochsner Clinic, New Orleans

72211

Arkansas Heart, Little Rock

85054

Mayo Clinic Phoenix, Phoenix

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT00228384 - GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study | Biotech Hunter | Biotech Hunter